newsfilter
← Latest News
GlobeNewswire·

ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

RAMSEY, N.J. and BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) ("ADMA" or the "Company"), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to